Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India

Indian Journal of Medical Microbiology

Volumn 31, Issue 3, 2013, Pages 230-236

  Maurya, A ^a   Singh, A ^a   Kant, S ^a   Umrao, J ^a   Kumar, M ^a   Kushwaha, Ras ^a   Nag, V ^a   Dhole, T ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

M. tuberculosis complex; MDR TB; tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ARTICLE; ASSAY; BACTERIAL MUTATION; CODON; DIAGNOSTIC EQUIPMENT; DRUG RESISTANCE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICROSCOPY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

EID: 84883179821     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.115625     Document Type: Article

References (38)

1. Deivanayagam CN, Rajasekaran S, Venkatesan R, Mahilmaran A, Ahmed PR, Annadurai S, et al. Prevalence of acquired MDR-TB and HIV co-infection. Indian J Chest Dis Allied Sci 2002;44:237-42.
2. World Health Organization. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World. Report No.
3. Geneva, Switzerland: WHO; WHO/HTM/TB/2008.394. [Last accessed 2012 Aug 28].
4. Sharma SK, Kumar S, Saha PK, George N, Arora SK, Gupta D, et al. Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian J Med Res 2011;133:312-5.
5. Kant S, Maurya AK, Kushwaha RA, Nag VL, Prasad R. Multi-drug resistant tuberculosis: An iatrogenic problem. Biosci Trends 2010;4:48-55.
6. Vijdea R, Stegger M, Sosnovskaja A, Andersen AB, Thomsen VO, Bang D. Multidrug-resistant tuberculosis: Rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates. Eur J Clin Microbiol Infect Dis 2008;27:1079-86.
7. Jureen P, Engstrand L, Eriksson S, Alderborn A, Krabbe M, Hoffner SE. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol 2006;44:1925-9.
8. Nikolayevskyy V, Balabanova Y, Simak T, Malomanova N, Fedorin I, Drobniewski F. Performance of the Genotype MTBDRplus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin Pathol 2009;9:2.
9. Brown TJ, Herrera-Leon L, Anthony RM, Drobniewski FA. The use of macroarrays for the identification of MDR Mycobacterium tuberculosis. J Microbiol Methods 2006;65:294-300.
10. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005;43:3699-703.
11. World Health Organisation: Policy Statement. Molecular Line Probe Assays for Rapid Screening of patients at risk of multidrug resistant tuberculosis (MDR-TB), 2008. Available from: http://www.who.int/tb/dots/laboratory/lpa- policy.pdf. [Last accessed on 2012 Aug 18].
12. Bang D, Bengard Andersen A, Thomsen VO. Rapid genotypic detection of rifampin-.and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol 2006;44:2605-8.
13. Bartfai Z, Somoskovi A, Kodmon C, Szabo N, Puskas E, Kosztolanyi L, et al. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 2001;39:3736-9.
14. Maurya AK, Kant S, Kushwaha RA, Nag VL. Molecular mechanism of first line anti-tuberculosis drugs in drug resistant mycobacterium tuberculosis. J Pharm Biomed Sci 2011;3:1-5.
15. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 2002;46:1417-24.
16. Musser JM, Kapur V, Williams DL, Kreiswirth BN, van Soolingen D, van Embden JD. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and - susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: Restricted array of mutations associated with drug resistance. J Infect Dis 1996;173:196-202.
17. Telenti A, Honore N, Bernasconi C, March J, Ortega A, Heym B, et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level. J Clin Microbiol 1997;35:719-23.
18. Kelley CL, Rouse DA, Morris SL. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997;41:2057-8.
19. Baron EJ, Finagold SM. Mycobacteria. In: Nancy, editor. Baily and Scott?s Diagnostic Microbiology. 9th ed. St. Luis: The CV Mosby Company; 1994. p. 590-633.
20. Scott CP, Dos Anjos Filho L, De Queiroz Mello FC, Thornton CG, Bishai WR, Fonseca LS, et al. Comparison of C (18)-carboxypropylbetaine and standard N-acetyl-L-cysteine-NaOH processing of respiratory specimens for increasing tuberculosis smear sensitivity in Brazil. J Clin Microbiol 2002;40:3219-22.
21. Angeby KA, Werngren J, Toro JC, Hedstrom G, Petrini B, Hoffner SE. Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis. Clin Microbiol Infect 2003;9:1148-52.
22. Kubica GP. Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria. Am Rev Respir Dis 1973;107:9-21.
23. Makinen J, Marjamaki M, Marttila H, Soini H. Evaluation of a novel strip test, GenoType Mycobacterium CM/AS, for species identification of mycobacterial cultures. Clin Microbiol Infect 2006;12:481-3.
24. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006;44:2338-42.
25. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006;44:2485-91.
26. Makinen J, Marttila HJ, Marjamaki M, Viljanen MK, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44:350-2.
27. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low-.and high-level resistance. J Clin Microbiol 2006;44:3659-64.
28. Barnard M, Albert H, Coetzee G, O?Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-92.
29. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007;45:2635-40.
30. Zhuang Y, He X, Zhang X. [The studies on the molecular mechanism of rifampin-resistant Mycobacterium tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2000;23:711-4.
31. World Health Organisation. The Global MDR-TB and XDR-TB Response Plan; 2007-2008 WHO/HTM/TB/2007.387. Geneva: World Health Organization; 2008. [Last acessed on 2012 Aug 20].
32. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 2001;39:636-41.
33. Hillemann D, Kubica T, Rusch-Gerdes S, Niemann S. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany. Antimicrob Agents Chemother 2005;49:1229-31.
34. Marttila HJ, Soini H, Eerola E, Vyshnevskaya E, Vyshnevskiy BI, Otten TF, et al. A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob Agents Chemother 1998;42:2443-5.
35. Albert H, Bwanga F, Mukkada S, Nyesiga B, Ademun JP, Lukyamuzi G, et al. Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. BMC Infect Dis 2010;10:41.
36. Laszlo A. Tuberculosis: Laboratory aspects of diagnosis. CMAJ 1999;160:1725-9.
37. Johnson R, Jordaan AM, Pretorius L, Engelke E, van der SG, Kewley C, et al. Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 2006;10:68-73.
38. De Oliveira MM, da Silva Rocha A, Cardoso Oelemann M, Gomes HM, Fonseca L, Werneck-Barreto AM, et al. Rapid detection of resistance against rifampicin in isolates of Mycobacterium tuberculosis from Brazilian patients using a reverse-phase hybridization assay. J Microbiol Methods 2003;53:335-42